USA Cell-free Fetal DNA Testing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cell-free Fetal DNA Testing market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cell-free Fetal DNA Testing market. Detailed analysis of key players, along with key growth strategies adopted by Cell-free Fetal DNA Testing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Guardant Health, Inc

    • Illumina Inc

    • Allenex AB

    • Quest Diagnostics

    • Sequenom, Inc

    • Biocept, Inc

    • Agilent Technologies, Inc

    • Biodesix, Inc

    • CareDx, Inc

    • Roche Holdings AG

    By Type:

    • Abnormal Chromosome Number Detection

    • Gender Testing

    • Paternally Inherited Disorder Detection

    • Paternity testing

    • Otehrs

    By End-User:

    • Hospital

    • Clinic Center

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cell-free Fetal DNA Testing Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Abnormal Chromosome Number Detection from 2016 to 2027

      • 1.3.2 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Gender Testing from 2016 to 2027

      • 1.3.3 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Paternally Inherited Disorder Detection from 2016 to 2027

      • 1.3.4 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Paternity testing from 2016 to 2027

      • 1.3.5 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Otehrs from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Hospital from 2016 to 2027

      • 1.4.2 USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Clinic Center from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Cell-free Fetal DNA Testing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cell-free Fetal DNA Testing by Major Types

      • 3.4.1 Market Size and Growth Rate of Abnormal Chromosome Number Detection

      • 3.4.2 Market Size and Growth Rate of Gender Testing

      • 3.4.3 Market Size and Growth Rate of Paternally Inherited Disorder Detection

      • 3.4.4 Market Size and Growth Rate of Paternity testing

      • 3.4.5 Market Size and Growth Rate of Otehrs

    4 Segmentation of Cell-free Fetal DNA Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cell-free Fetal DNA Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cell-free Fetal DNA Testing in Hospital

      • 4.4.2 Market Size and Growth Rate of Cell-free Fetal DNA Testing in Clinic Center

    5 Market Analysis by Regions

    • 5.1 USA Cell-free Fetal DNA Testing Production Analysis by Regions

    • 5.2 USA Cell-free Fetal DNA Testing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Cell-free Fetal DNA Testing Landscape Analysis

    • 6.1 West USA Cell-free Fetal DNA Testing Landscape Analysis by Major Types

    • 6.2 West USA Cell-free Fetal DNA Testing Landscape Analysis by Major End-Users

    7 South USA Cell-free Fetal DNA Testing Landscape Analysis

    • 7.1 South USA Cell-free Fetal DNA Testing Landscape Analysis by Major Types

    • 7.2 South USA Cell-free Fetal DNA Testing Landscape Analysis by Major End-Users

    8 Middle West USA Cell-free Fetal DNA Testing Landscape Analysis

    • 8.1 Middle West USA Cell-free Fetal DNA Testing Landscape Analysis by Major Types

    • 8.2 Middle West USA Cell-free Fetal DNA Testing Landscape Analysis by Major End-Users

    9 Northeast USA Cell-free Fetal DNA Testing Landscape Analysis

    • 9.1 Northeast USA Cell-free Fetal DNA Testing Landscape Analysis by Major Types

    • 9.2 Northeast USA Cell-free Fetal DNA Testing Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Guardant Health, Inc

        • 10.1.1 Guardant Health, Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Illumina Inc

        • 10.2.1 Illumina Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Allenex AB

        • 10.3.1 Allenex AB Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Quest Diagnostics

        • 10.4.1 Quest Diagnostics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Sequenom, Inc

        • 10.5.1 Sequenom, Inc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Biocept, Inc

        • 10.6.1 Biocept, Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Agilent Technologies, Inc

        • 10.7.1 Agilent Technologies, Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Biodesix, Inc

        • 10.8.1 Biodesix, Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 CareDx, Inc

        • 10.9.1 CareDx, Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Roche Holdings AG

        • 10.10.1 Roche Holdings AG Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Abnormal Chromosome Number Detection from 2016 to 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Gender Testing from 2016 to 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Paternally Inherited Disorder Detection from 2016 to 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Paternity testing from 2016 to 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Otehrs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure USA Cell-free Fetal DNA Testing Market Size and Growth Rate of Clinic Center from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Cell-free Fetal DNA Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Cell-free Fetal DNA Testing

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cell-free Fetal DNA Testing by Different Types from 2016 to 2027

    • Table Consumption Share of Cell-free Fetal DNA Testing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Abnormal Chromosome Number Detection

    • Figure Market Size and Growth Rate of Gender Testing

    • Figure Market Size and Growth Rate of Paternally Inherited Disorder Detection

    • Figure Market Size and Growth Rate of Paternity testing

    • Figure Market Size and Growth Rate of Otehrs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Cell-free Fetal DNA Testing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Cell-free Fetal DNA Testing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic Center

    • Table USA Cell-free Fetal DNA Testing Production by Regions

    • Table USA Cell-free Fetal DNA Testing Production Share by Regions

    • Figure USA Cell-free Fetal DNA Testing Production Share by Regions in 2016

    • Figure USA Cell-free Fetal DNA Testing Production Share by Regions in 2021

    • Figure USA Cell-free Fetal DNA Testing Production Share by Regions in 2027

    • Table USA Cell-free Fetal DNA Testing Consumption by Regions

    • Table USA Cell-free Fetal DNA Testing Consumption Share by Regions

    • Figure USA Cell-free Fetal DNA Testing Consumption Share by Regions in 2016

    • Figure USA Cell-free Fetal DNA Testing Consumption Share by Regions in 2021

    • Figure USA Cell-free Fetal DNA Testing Consumption Share by Regions in 2027

    • Table West USA Cell-free Fetal DNA Testing Consumption by Types from 2016 to 2027

    • Table West USA Cell-free Fetal DNA Testing Consumption Share by Types from 2016 to 2027

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2016

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2021

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2027

    • Table West USA Cell-free Fetal DNA Testing Consumption by End-Users from 2016 to 2027

    • Table West USA Cell-free Fetal DNA Testing Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2016

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2021

    • Figure West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2027

    • Table South USA Cell-free Fetal DNA Testing Consumption by Types from 2016 to 2027

    • Table South USA Cell-free Fetal DNA Testing Consumption Share by Types from 2016 to 2027

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by Types in 2016

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by Types in 2021

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by Types in 2027

    • Table South USA Cell-free Fetal DNA Testing Consumption by End-Users from 2016 to 2027

    • Table South USA Cell-free Fetal DNA Testing Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2016

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2021

    • Figure South USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2027

    • Table Middle West USA Cell-free Fetal DNA Testing Consumption by Types from 2016 to 2027

    • Table Middle West USA Cell-free Fetal DNA Testing Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2016

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2021

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by Types in 2027

    • Table Middle West USA Cell-free Fetal DNA Testing Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Cell-free Fetal DNA Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2016

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2021

    • Figure Middle West USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2027

    • Table Northeast USA Cell-free Fetal DNA Testing Consumption by Types from 2016 to 2027

    • Table Northeast USA Cell-free Fetal DNA Testing Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by Types in 2016

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by Types in 2021

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by Types in 2027

    • Table Northeast USA Cell-free Fetal DNA Testing Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Cell-free Fetal DNA Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2016

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2021

    • Figure Northeast USA Cell-free Fetal DNA Testing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Guardant Health, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guardant Health, Inc

    • Figure Sales and Growth Rate Analysis of Guardant Health, Inc

    • Figure Revenue and Market Share Analysis of Guardant Health, Inc

    • Table Product and Service Introduction of Guardant Health, Inc

    • Table Company Profile and Development Status of Illumina Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina Inc

    • Figure Sales and Growth Rate Analysis of Illumina Inc

    • Figure Revenue and Market Share Analysis of Illumina Inc

    • Table Product and Service Introduction of Illumina Inc

    • Table Company Profile and Development Status of Allenex AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allenex AB

    • Figure Sales and Growth Rate Analysis of Allenex AB

    • Figure Revenue and Market Share Analysis of Allenex AB

    • Table Product and Service Introduction of Allenex AB

    • Table Company Profile and Development Status of Quest Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics

    • Figure Revenue and Market Share Analysis of Quest Diagnostics

    • Table Product and Service Introduction of Quest Diagnostics

    • Table Company Profile and Development Status of Sequenom, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sequenom, Inc

    • Figure Sales and Growth Rate Analysis of Sequenom, Inc

    • Figure Revenue and Market Share Analysis of Sequenom, Inc

    • Table Product and Service Introduction of Sequenom, Inc

    • Table Company Profile and Development Status of Biocept, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept, Inc

    • Figure Sales and Growth Rate Analysis of Biocept, Inc

    • Figure Revenue and Market Share Analysis of Biocept, Inc

    • Table Product and Service Introduction of Biocept, Inc

    • Table Company Profile and Development Status of Agilent Technologies, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies, Inc

    • Figure Sales and Growth Rate Analysis of Agilent Technologies, Inc

    • Figure Revenue and Market Share Analysis of Agilent Technologies, Inc

    • Table Product and Service Introduction of Agilent Technologies, Inc

    • Table Company Profile and Development Status of Biodesix, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biodesix, Inc

    • Figure Sales and Growth Rate Analysis of Biodesix, Inc

    • Figure Revenue and Market Share Analysis of Biodesix, Inc

    • Table Product and Service Introduction of Biodesix, Inc

    • Table Company Profile and Development Status of CareDx, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CareDx, Inc

    • Figure Sales and Growth Rate Analysis of CareDx, Inc

    • Figure Revenue and Market Share Analysis of CareDx, Inc

    • Table Product and Service Introduction of CareDx, Inc

    • Table Company Profile and Development Status of Roche Holdings AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Holdings AG

    • Figure Sales and Growth Rate Analysis of Roche Holdings AG

    • Figure Revenue and Market Share Analysis of Roche Holdings AG

    • Table Product and Service Introduction of Roche Holdings AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.